BSE - Free Realtime Quote INR

Sequent Scientific Limited (SEQUENT.BO)

166.95
+6.10
+(3.79%)
As of 1:17:04 PM GMT+5:30. Market Open.
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
15,074,400
13,663,000
14,182,750
14,101,720
13,520,350
Cost of Revenue
8,600,050
8,131,150
8,985,120
8,444,360
7,365,620
Gross Profit
6,474,350
5,531,850
5,197,630
5,657,360
6,154,730
Operating Expense
5,373,940
5,161,640
5,194,780
4,983,410
4,402,510
Operating Income
1,100,410
370,210
2,850
673,950
1,752,220
Net Non Operating Interest Income Expense
-573,960
-474,160
-343,080
-155,330
-237,570
Pretax Income
306,340
-546,460
-1,376,580
529,300
1,366,290
Tax Provision
74,820
-250,330
-156,810
81,660
321,770
Net Income Common Stockholders
116,510
-358,690
-1,211,590
409,550
954,420
Diluted NI Available to Com Stockholders
116,510
-358,690
-1,211,590
409,550
954,420
Basic EPS
0.47
-1.44
-4.88
1.65
3.87
Diluted EPS
0.46
-1.44
-4.88
1.63
3.85
Basic Average Shares
251,067.08
248,624.52
248,471.25
247,408.75
246,879.75
Diluted Average Shares
256,170.26
249,882.81
250,114.40
250,733.25
247,870.49
Rent Expense Supplemental
--
42,460
34,040
19,940
10,410
Total Expenses
13,973,990
13,292,790
14,179,900
13,427,770
11,768,130
Net Income from Continuing & Discontinued Operation
116,510
-358,690
-1,211,590
409,550
954,420
Normalized Income
144,344.70
-219,719
-300,028.90
411,469.74
1,019,677.72
Interest Income
--
6,700
12,090
2,410
6,260
Interest Expense
564,030
464,230
297,190
135,090
192,540
Net Interest Income
-573,960
-474,160
-343,080
-155,330
-237,570
EBIT
870,370
-82,230
-1,079,390
664,390
1,558,830
EBITDA
1,538,470
533,170
-522,460
1,179,800
2,064,810
Reconciled Cost of Revenue
8,600,050
8,131,150
8,985,120
8,444,360
7,365,620
Reconciled Depreciation
668,100
615,400
556,930
515,410
505,980
Net Income from Continuing Operation Net Minority Interest
116,510
-358,690
-1,211,590
409,550
954,420
Total Unusual Items Excluding Goodwill
-36,830
-198,530
-798,410
-2,270
-85,360
Total Unusual Items
-36,830
-198,530
-594,320
-2,270
-85,360
Normalized EBITDA
1,575,300
731,700
71,860
1,182,070
2,150,170
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-8,995.30
-59,559
-90,938.90
-350.26
-20,102.28
3/31/2021 - 1/5/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SHILPAMED.BO Shilpa Medicare Limited
659.90
+3.33%
 
IOLCP.BO IOL Chemicals and Pharmaceuticals Limited
64.78
+4.35%
 
AARTIDRUGS.BO Aarti Drugs Limited
429.20
+2.64%
 
GRANULES.BO Granules India Limited
455.45
+3.19%
 
MANKIND.BO Mankind Pharma Limited
2,510.00
+4.00%
 
LAURUSLABS.BO Laurus Labs Limited
591.70
+0.48%
 
TORNTPHARM.NS Torrent Pharmaceuticals Limited
3,205.10
+2.03%